SMN1 and proximal spinal muscular atrophy: Interestingly, SMA patients in the adeno-associated virus serotype 9 (AAV9)-SMN1 gene therapy clinical trial also received prednisolone (1 mg/kg) one day pre-gene therapy and for 30 days thereafter [88].